Found 4363 articles for: ""
Lichen Planus Pigmentosus Presenting as Diffuse Facial Melanosis
July 2004 | Volume 3 | Issue 4 | Case Reports | 436 | Copyright © July 2004
Lichen planus pigmmentosus (LPP), an uncommon variant of lichen planus, has been characterized by hyperpigmented, dark brown macules in sun-exposed areas and flexural folds. In this paper, an unusual...
Read MoreDisseminate and Recurrent Infundibulofolliculitis: Response to Isotretinoin
July 2004 | Volume 3 | Issue 4 | Case Reports | 434 | Copyright © July 2004
Disseminate and recurrent infundibulofolliculitis (DRIF) is a rarely-reported disorder. Here, the authors describe a case in which isotretinoin was successfully used to treat DRIF...
Read MoreThe Use of Sulfur in Dermatology
July 2004 | Volume 3 | Issue 4 | Original Article | 427 | Copyright © July 2004
Sulfur has antifungal, antibacterial, and keratolytic activity. In the past, its use was widespread in dermatological disorders such as acne vulgaris, rosacea, seborrheic dermatitis, dandruff, pityri...
Read MoreA Double-Blinded Randomized Trial Testing the Tolerability and Efficacy of a Novel Topical Agent With and Without Occlusion for the Treatment of Cellulite: A Study and Review of the Literature
July 2004 | Volume 3 | Issue 4 | Original Article | 417 | Copyright © July 2004
Cellulite is the unsightly dimpling and nodularity frequently found on the thighs and buttocks of post-adolescent women. The anatomy and pathophysiology of this unwanted condition is poorly understoo...
Read MoreTelithromycin: A Brief Review of a New Ketolide Antibiotic
July 2004 | Volume 3 | Issue 4 | Original Article | 409 | Copyright © July 2004
Telithromycin (Ketek™, Aventis) is a semisynthetic antibacterial agent belonging to a class of drugs called ketolides, which are a variation on the existing class of antibiotics known as macrolides...
Read MorePhase IV, Open-Label Assessment of the Treatment of Actinic Keratosis With 3.0% Diclofenac Sodium Topical Gel (Solaraze™)
July 2004 | Volume 3 | Issue 4 | Original Article | 401 | Copyright © July 2004
A clearance rate of all occurrences ?75% for actinic keratoses (AK) lesions is an accepted efficacy endpoint for topical agents. This efficacy endpoint has not been assessed for 3.0% diclofenac sodiu...
Read MoreOverview on Desonide 0.05%: A Clinical Safety Profile
July 2004 | Volume 3 | Issue 4 | Original Article | 393 | Copyright © July 2004
Desonide (as a cream, ointment, or lotion formulation) is widely used for the treatment of steroid-responsive dermatoses. This paper provides information on its safety record, as determined from adve...
Read MorePoly-L-lactic Acid: A Temporary Filler for Soft Tissue Augmentation
July 2004 | Volume 3 | Issue 4 | Original Article | 385 | Copyright © July 2004
A number of soft tissue filling agents are available in the U.S. and Europe. In Europe, poly-L-lactic acid was approved for soft tissue augmentation and correction of wrinkles in 1999. The clinical r...
Read MoreImproved Quality of Life with Treatment of Facial Melasma: The Pigment Trial
July 2004 | Volume 3 | Issue 4 | Original Article | 377 | Copyright © July 2004
Melasma is a common hyperpigmentation of the face or neck that can have severe adverse psychological and emotional effects on affected individuals. Although a variety of treatments have been used ove...
Read MoreClobetasol Propionate Shampoo 0.05%: A New Option to Treat Patients with Moderate to Severe Scalp Psoriasis
July 2004 | Volume 3 | Issue 4 | Original Article | 367 | Copyright © July 2004
Psoriasis is a chronic, papulosquamous condition that affects up to 2% of the U.S. population. Approximately 50% of patients with psoriasis have involvement of the scalp.
This was a multicen...
Read MorePalmar Erythema due to Topiramate
May 2004 | Volume 3 | Issue 3 | Case Reports | 321 | Copyright © May 2004
Topiramate is an anti-convulsant often used off-label for the treatment of several conditions, including obesity and schizophrenia. This case report describes palmar erythema as a side effect in a pa...
Read MoreCounter-Regulatory Balance: Atopic Dermatitis in Patients Undergoing Infliximab Infuson Therapy
May 2004 | Volume 3 | Issue 3 | Case Reports | 315 | Copyright © May 2004
Atopic dermatitis has been characterized as an autoimmune or auto-allergic phenomenon in which environmental allergens resembling human proteins activate auto-reactive T-cells to release pro-inflamma...
Read MoreLupus Erythematosus and Lichen Planus Overlap Symdrome
May 2004 | Volume 3 | Issue 3 | Case Reports | 311 | Copyright © May 2004
A case of lupus erythematosus (LE) and lichen planus (LP) overlap syndrome in a 71-year-old woman is presented. This disease displays characteristics of both LE and LP. The clinical, histologic, and ...
Read MoreSolitary Mastocytoma Successfully Treated with a Moderate Potency Topical Steriod
May 2004 | Volume 3 | Issue 3 | Case Reports | 309 | Copyright © May 2004
We report a case of solitary mastocytoma in a child which was successfully treated with a topical steroid of moderate potency. The patient was an 18-month-old girl who presented with localized oval s...
Read MoreSerum Sickness due to Infliximab in a Patient with Psoriasis
May 2004 | Volume 3 | Issue 3 | Case Reports | 305 | Copyright © May 2004
Infliximab is a chimeric, murine-human, monoclonal antibody against tumor necrosis alpha which has shown great efficacy in the treatment of psoriasis. Serum sickness, which is an immune complex media...
Read MoreFollicular Mycosis Fungoides: Successful Treatment with Oral Bexarotene
May 2004 | Volume 3 | Issue 3 | Case Reports | 301 | Copyright © May 2004
Follicular mycosis fungoides, a subtype of cutaneous T-cell lymphoma, is often difficult to treat. We present a case of a female with follicular mycosis fungoides who showed an excellent response to ...
Read MoreThe IFRA: Working Towards the Continually-Improved Safety of Fragrance Ingedients and the Importance of a Partnership with the Dermatological Community
May 2004 | Volume 3 | Issue 3 | Original Article | 297 | Copyright © May 2004
The relationship between the fragrance industry and the dermatological community in the past has not always been perceived as one of partnership. IFRA, the International Fragrance Association, has st...
Read MoreAntiandrogen Oligonucleotides: Active Principles in Hair-and Skin-Derived Culute Cells
May 2004 | Volume 3 | Issue 3 | Original Article | 287 | Copyright © May 2004
Most drugs used for treatment of androgen-related dermatological disorders are not completely satisfactory in terms of clinical efficacy and potential secondary effects. There is, therefore, a need f...
Read MoreOff-label Uses and Side Effects of Infliximab
May 2004 | Volume 3 | Issue 3 | Original Article | 273 | Copyright © May 2004
Infliximab was first approved by the FDA in 1998 as a treatment of moderately-to-severely active Crohn’s disease in patients who have an inadequate response to conventional therapies, and fistulizi...
Read MoreEtanercept for the Treatment of Psoriasis: Combination Therapy with other Modalities
May 2004 | Volume 3 | Issue 3 | Original Article | 270 | Copyright © May 2004
Etanercept is a self-administered medication that has FDA approval for the treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Etanercep...
Read More